The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 16th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Cushing's Disease: Data Hints at the Diagnosis
February 3rd 2016Cushing’s disease, caused by excessive adrenocorticotropic hormone production from a pituitary adenoma, is rare and can be difficult for non-endocrinologists to diagnose. As it can cause other serious conditions getting a diagnosis as quickly as possible can be critical for the overall health of patients.
MDs on Gun Violence: Ten Angry Answers
January 25th 2016More than 900 physicians who subscribe to MD Magazine’s email news took the time last week to answer a seven-question survey on whether physicians should play a role in curbing gun violence. Here are the ten most passionate responses, taken from both sides
Endoscopic Sleeve Gastroplasty Could Be the New Way to Lose Weight
Although bariatric surgery is currently the most effective treatment against obesity, only 1-2% of qualified patients are able to undergo this procedure due to limited access, patient choice, associated risks, and expensive costs.
Study Shows Some Positive Signs for Pancrelipase Against Non-Alcoholic Fatty Liver Disease
A new randomized controlled trial hints that pancrelipase may do better than conventional pancreatic enzyme supplementation in protecting against non-alcoholic fatty liver disease in pancreatic cancer patients who undergo pancreatoduodenectomy.
Brooke Army Medical Center: The Heart of Military Medicine from the Heart of Texas
One of the most important facilities in the American military medical system is Brooke Army Medical Center. As a level 1 trauma center and a key research facility the San Antonio institution plays many roles all with one goal in mind.
Amid Obesity Epidemic, the Twinkie Diet?
A nutritionist's odd diet may call into question much of what your patients are often told about the need to consume “healthy†foods to affect certain markers of health, such as body mass index and levels of “good†and “bad†cholesterol levels.
Patients Unlikely to Change Dietary Habits After Diabetes Diagnosis, Despite Health Benefits
January 14th 2016Ideally, patients diagnosed with type 2 diabetes, metabolic syndrome, or obesity would take steps to address lifestyle factors. Often, their treatment teams are disappointed when these patients fail either to improve their diets or make healthy changes.
Sorting Out the Repercussions of Gender Dysphoria
January 14th 2016Gender dysphoria--a discrepancy between an individual's anatomic sex assigned at birth and the gender he or she identifies with--creates considerable internal distress. Affected individuals report strong desires to live as their preferred gender.
Diabetes and Ramadan: Gathering Data to Improve Clinical Care While Fasting
January 14th 2016Muslims engage in an obligatory, month-long, sunrise-to-sunset fast once a year during Ramadan. In 2005, the American Diabetes Association developed recommendations for managing diabetes during Ramadan. They updated the recommendations in 2010, and this document has become one of their more popular publications.
Community Program Aims to Reduce Disparities in Diabetes Care
January 14th 2016When patients who are socioeconomically deprived develop diabetes, the course of their illness is usually more complicated than that of patients who have better resources. Many of these patients have high levels of mental illness, multiple comorbidities, and unmet needs.
Blood Test Guides Individualized Pancreatic Cancer Treatment
Testing for the CA 19-9 tumor marker is especially important for early stage pancreatic cancer patients, but only about 20% of patients receive the test, according to findings presented at the Western Surgical Association meeting in November 2015 in Napa, CA.
Sanofi Pulls Plug on Afrezza Deal, Putting Drug's Future in Doubt
Shockingly poor sales have led Sanofi to opt out of its deal to sell the inhalable insulin Afrezza for the company that developed it, a move that led shares of California-based Mannkind to fall 48% yesterday despite management’s promise to find a more effective marketing partner.